Claar Advisors’s Labcorp LH Stock Holding History

Claar Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-104,760	Closed	-$13.9M	–	40
2017 Q2	$13.9M	Hold	104,760	–	–	3.94%	9
2017 Q1	$12.9M	Hold	104,760	–	–	4.51%	9
2016 Q4	$11.6M	Buy	104,760 +46,560	+80%	+$5.17M	5.43%	9
2016 Q3	$6.87M	Hold	58,200	–	–	3.48%	11
2016 Q2	$6.51M	Buy	58,200 +5,820	+11%	+$626K	3.24%	12
2016 Q1	$5.27M	Buy	+52,380	New	+$5.02M	2.74%	11

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Claar Advisors's LH Position: Q3 2017 in Review

Claar Advisors sold out of Labcorp (LH) in Q3 2017, closing a stake of 104,760 shares — an estimated $13.9M sold.

Claar Advisors first reported a position in LH in Q1 2016 and held it in 6 quarters. The position peaked at $13.9M in Q2 2017. 701 funds tracked by Wall St. Rank hold LH as of Q3 2017.

Claar Advisors reported no remaining Labcorp position as of Q3 2017 after selling out during the quarter.
Claar Advisors sold 104,760 Labcorp shares in Q3 2017, an estimated $13.9M.
Claar Advisors first reported a position in Labcorp in Q1 2016 and held it in 6 quarters.
Claar Advisors's Labcorp position peaked at $13.9M in Q2 2017.
701 funds tracked by Wall St. Rank held Labcorp as of Q3 2017.

Based on Claar Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.